or Try an Advanced Search...

    Stage Pharmaceutical Stocks List

    Symbol Grade Name % Change
    RVPH F Reviva Pharmaceuticals Holdings, Inc. -8.06
    CNSP F CNS Pharmaceuticals, Inc. -4.31
    PSTV F Plus Therapeutics, Inc. -1.67
    SVRA D Savara, Inc. 3.70
    KALV D KalVista Pharmaceuticals, Inc. 8.85
    CASI D CASI Pharmaceuticals, Inc. -2.86
    HRMY D Harmony Biosciences Holdings, Inc. 2.53
    MBRX D Moleculin Biotech, Inc. -3.53
    KPTI C Karyopharm Therapeutics Inc. 8.67
    CRMD C CorMedix Inc -3.58
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Pharmaceutical Cancer Medicine Disease Blastoma Glioblastoma Oncology Chemotherapy Chloroarenes Clinical Medicine Drugs Multiple Myeloma Ovarian Cancer Treatment Of Cancer Acute Myeloid Leukemia Advanced Solid Tumors Angioedema Antibody Drug Conjugate Antineoplastic Drugs Autoimmune Disease

    Related ETFs - A few ETFs which own one or more of the above listed Stage Pharmaceutical stocks.

    Symbol Grade Name Weight
    BBP C BioShares Biotechnology Products Fund 1.67
    CNCR F Loncar Cancer Immunotherapy ETF 1.57
    JSML B Janus Small Cap Growth Alpha ETF 1.33
    XPH B SPDR S&P Pharmaceuticals ETF 1.22
    GRPZ A Invesco Exchange-Traded Fund Trust II Invesco S&P SmallCap 600 GARP ETF 0.96
    View all Stage Pharmaceutical ETFs...
    Compare ETFs
    Compare BBP to JSML Compare CNCR to XPH Compare JSML to GRPZ

        Stage Pharmaceutical Stocks Recent News

        Date Stock Title
        Nov 22 SVRA Savara Announces Encore Presentation of Results from the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the British Thoracic Society Winter Meeting 2024
        Nov 22 PSTV Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases
        Nov 21 HRMY HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
        Nov 21 PSTV Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide™ Cerebrospinal Fluid Assay in Patients with Leptomeningeal Metastases
        Nov 20 KPTI Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer
        Nov 19 RVPH RVPH: Year-End OLE Update
        Nov 18 CNSP CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
        Nov 18 KPTI Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Pharmaceutical Cancer Medicine Disease Blastoma Glioblastoma Oncology Chemotherapy Chloroarenes Clinical Medicine Drugs Multiple Myeloma Ovarian Cancer Treatment Of Cancer Acute Myeloid Leukemia Advanced Solid Tumors Angioedema Antibody Drug Conjugate Antineoplastic Drugs Autoimmune Disease
        Stage Pharmaceutical

        Stage Pharmaceutical is a biopharmaceutical company focused on developing innovative treatments for rare and neglected diseases. The company is developing a portfolio of novel therapies for rare and neglected diseases, including rare genetic disorders, rare cancers, and rare infectious diseases. Stage Pharmaceutical is committed to developing treatments that are safe, effective, and affordable for patients.

        Browse All Tags